Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenyl salicylate is a small molecule drug classified as a 2-hydroxybenzoic acid phenyl ester. It acts as a mild analgesic and is used primarily for pain relief by releasing salicylate (the active component in aspirin). Its mechanism of action involves inhibition of cyclooxygenase (COX) enzymes—specifically prostaglandin G/H synthase 1 and 2—thereby reducing the formation of prostaglandins responsible for inflammation and pain. Phenyl salicylate is also found in combination products for urinary tract discomfort or infection-related symptoms. Beyond pharmaceuticals it has industrial uses in manufacturing polymers and other materials[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phenyl salicylate.